Regentis Biomaterials Company

Regentis Biomaterials Ltd., a tissue repair company, develops and commercializes biodegradable hydrogels for the repair of damaged cartilage tissue. It offers GelrinC, a biodegradable hydrogel platform for the repair of cartilage defects that include micro fracture, mosaicplasty, osteochondral autologous (or autograft) transplantation system, and autologous chondrocyte implantation, as well as for the treatment of painful injuries to articular knee cartilage; and Gelrin, a hydrogel matrix of polyethylene glycol diacrylate (PEG-DA) and denatured fibrinogen that combines the stability and versatility of a synthetic material with the bio-functionality of a natural substance.
Technology: Biotechnology, Health Care, Medical Device
Industry: Regenerative Medicine
Headquarters: Or Akiva, Hefa, Israel
Founded Date: 2004
Employees Number: 11-50
Funding Status: Late Stage Venture

Visit Website
Register and Claim Ownership